Effect of hepatitis C virus infection on postoperative adjuvant chemotherapy in patients with gastrointestinal cancer
Objective To investigate the effect of hepatitis C virus(HCV)infection on postoperative adjuvant chemotherapy in patients with gastrointestinal cancer.Methods The patients with gastrointestinal cancer and HCV infection who needed immediate postoperative adjuvant chemotherapy were retrospectively selected as study group(29 cases),and the patients with gastrointestinal cancer who were HCV negative received postoperative adjuvant chemotherapy were selected as control group(59 cases).The general information and clinical characteristics of the two groups were compared,and the effect of HCV infection on postoperative adjuvant chemotherapy in patients with gastrointestinal cancer was analyzed.Results The baseline alanine transaminase(ALT)level of the study group was higher than that of the control group,and the increase of ALT level after chemotherapy was more significant(P<0.05).The total incidences of severe adverse events(SAEs)and adverse events(AEs)in the study group were higher than those in the control group(P<0.05).The probability of chemotherapy delay and chemotherapy drug reduction in the study group were significantly higher than those in the control group,and the differences were statistically significant(P<0.05).Conclusion The patients with HCV-positive gastrointestinal cancer are more likely to have adverse reactions during postoperative adjuvant chemotherapy;HCV pasitive hinders the successful completion of chemotherapy and should be closely monitored.
hepatitis C virusgastrointestinal cancerchemotherapydirect antiviral drugdrug interactionalanine transaminasesevere adverse event